Related Experiment Videos
Captopril in severe preeclampsia
M M Taslimi1, A R Harbin, A Gonzalez-Ruiz
1Department of Obstetrics and Gynecology, University of Tennessee College of Medicine, Chattanooga.
Journal of the National Medical Association
|August 1, 1991
Summary
Sublingual captopril effectively managed postpartum hypertension in severe preeclampsia patients. This treatment showed safety and efficacy, with normal blood pressures achieved postpartum.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Cardiovascular Medicine
Background:
- Severe preeclampsia poses risks, often requiring postpartum hypertension management.
- Captopril, an angiotensin-converting enzyme inhibitor, has limited use in pregnancy due to fetal concerns.
- Postpartum hypertension management strategies are crucial for maternal health.
Purpose of the Study:
- To evaluate the efficacy and safety of sublingual captopril for managing severe postpartum preeclampsia.
- To assess captopril's impact on blood pressure and pulse rate in the postpartum period.
Main Methods:
- A study involving patients with severe preeclampsia in the postpartum period.
- Administration of sublingual captopril to assess its antihypertensive effects.
- Monitoring of systolic and diastolic blood pressures and pulse rates over 24 hours.
- Comparison of captopril responders with those requiring alternative antihypertensive agents.
Main Results:
- Two patients achieved normal blood pressure with sublingual captopril.
- Three patients showed moderate response and were switched to other antihypertensives (hydralazine, clonidine, nifedipine).
- Captopril did not significantly increase pulse rates; no adverse effects were reported. All patients normalized blood pressure by 6 weeks postpartum.
Conclusions:
- Sublingual captopril appears to be a safe and effective option for managing postpartum hypertension in severe preeclampsia.
- Further research may support captopril's role in postpartum care for hypertensive disorders of pregnancy.